全球分子检测方法市场规模、份额、趋势和成长分析报告（2026-2034）

预计分子诊断市场将从 2025 年的 122.7 亿美元成长到 2034 年的 315.7 亿美元，2026 年至 2034 年的复合年增长率为 11.07%。

受对先进诊断和检测技术需求不断增长的推动，全球分子检测方法市场正经历强劲增长。 PCR、定序和杂合反应等分子检测方法在遗传疾病和感染疾病的检测中发挥着至关重要的作用。生物技术和生命科学研究领域投资的不断增加也显着促进了市场成长。

成长要素包括感染疾病的蔓延和个人化医疗的日益普及。研究实验室和机构正在投资建造自动化、高通量分子检测平台。核酸扩增和定序技术的进步正在提高检测的准确性和效率。此外，发展中地区医疗基础设施的扩建也进一步刺激了需求。

随着分子诊断在精准医疗中扮演越来越重要的角色，其未来前景依然强劲。人工智慧在数据分析的应用将提升检测结果的解读准确性。新兴市场对检查室现代化改造的投资将创造更多成长机会。随着基因研究和疾病早期检测重要性的日益凸显，全球分子诊断市场预计将稳定扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球分子方法市场：依技术划分

• 市场分析、洞察与预测
• PCR
• 定序
• 微阵列
• 杂合反应
• 其他的

第五章 全球分子方法市场：依应用划分

• 市场分析、洞察与预测
• 临床诊断
• 研究
• 法医学
• 环境测试
• 其他的

第六章：全球分子方法市场：依最终用户划分

• 市场分析、洞察与预测
• 医院/诊断检查室
• 学术研究机构
• 製药和生物技术公司
• 其他的

第七章 全球分子方法市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Merck KGaA
  • QIAGEN NV
  • Becton
  • Dickinson And Company
  • Agilent Technologies Inc
  • Illumina Inc
  • Bio-Rad Laboratories Inc
  • PerkinElmer Inc
  • GE HealthCare Technologies Inc
  • BioMAfA（C）Rieux SA
  • Takara Bio Inc

The Molecular Methods Market size is expected to reach USD 31.57 Billion in 2034 from USD 12.27 Billion (2025) growing at a CAGR of 11.07% during 2026-2034.

The Global Molecular Methods Market is experiencing robust growth driven by increasing demand for advanced diagnostic and research techniques. Molecular methods such as PCR, sequencing, and hybridization play a crucial role in detecting genetic disorders and infectious diseases. Rising investments in biotechnology and life sciences research are significantly supporting market expansion.

Major growth drivers include growing prevalence of infectious diseases and increasing adoption of personalized medicine. Laboratories and research institutions are investing in automated and high-throughput molecular testing platforms. Technological advancements in nucleic acid amplification and sequencing technologies are enhancing accuracy and efficiency. Additionally, expanding healthcare infrastructure in developing regions is further boosting demand.

Future prospects remain strong as molecular diagnostics become central to precision healthcare. Integration of artificial intelligence in data analysis will improve test interpretation. Emerging markets investing in laboratory modernization will create additional growth opportunities. As genetic research and early disease detection gain importance, the Global Molecular Methods Market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• PCR
• Sequencing
• Microarray
• Hybridization
• Others

By Application

• Clinical Diagnostics
• Research
• Forensic
• Environmental Testing
• Others

By End-User

• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Danaher Corporation, Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Merck KGaA, QIAGEN NV, Becton, Dickinson and Company, Agilent Technologies Inc, Illumina Inc, BioRad Laboratories Inc, PerkinElmer Inc, GE HealthCare Technologies Inc, bioMrieux SA, Takara Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MOLECULAR METHODS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MOLECULAR METHODS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Environmental Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MOLECULAR METHODS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MOLECULAR METHODS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MOLECULAR METHODS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Danaher Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Siemens Healthineers AG
  • 9.2.6 Merck KGaA
  • 9.2.7 QIAGEN N.V
  • 9.2.8 Becton
  • 9.2.9 Dickinson And Company
  • 9.2.10 Agilent Technologies Inc
  • 9.2.11 Illumina Inc
  • 9.2.12 Bio-Rad Laboratories Inc
  • 9.2.13 PerkinElmer Inc
  • 9.2.14 GE HealthCare Technologies Inc
  • 9.2.15 BioMAfA(C)Rieux SA
  • 9.2.16 Takara Bio Inc